Pro Medicus Limited

ASX-PME
Australian Securities Exchange
Healthcare Health Information Services
Global Rank
#1111
Country Rank
#22
Market Cap
18.87 B
Price
183.09
Change (%)
1.35%
Volume
48,033

Pro Medicus Limited's latest marketcap:

18.87 B

As of 06/26/2025, Pro Medicus Limited's market capitalization has reached $18.87 B. According to our data, Pro Medicus Limited is the 1111th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 18.87 B
Revenue (ttm) 120.36 M
Net Income (ttm) 64.09 M
Shares Out 104.46 M
EPS (ttm) 0.61
Forward PE 213.75
Ex-Dividend Date 02/27/2025
Earnings Date 08/14/2025
Market Cap Chart
Data Updated: 06/26/2025

Pro Medicus Limited's yearly market capitalization.

Pro Medicus Limited has seen its market value grow from A$109.29 M to A$18.87 B since 2014, representing a total increase of 17,167.25% and an annual compound growth rate (CAGR) of 63.44%.
Date Market Cap Change (%) Global Rank
06/26/2025 A$18.87 B 8.83% 1111
12/31/2024 A$26.14 B 161.11% 1137
12/29/2023 A$10.01 B 73.45% 2227
12/30/2022 A$5.77 B -11.46% 3289
12/31/2021 A$6.52 B 83.09% 3368
12/31/2020 A$3.56 B 53.23% 4389
12/31/2019 A$2.32 B 106.08% 5154
12/31/2018 A$1.13 B 25.1% 6975
12/29/2017 A$901.16 M 82.88% 8761
12/30/2016 A$492.77 M 44.64% 10616

Company Profile

About Pro Medicus Limited

Pro Medicus Limited is a leading healthcare informatics company specializing in the development and supply of advanced medical imaging software and radiology information systems (RIS). The company serves hospitals, imaging centers, and healthcare groups across Australia, North America, and Europe.

Key Products & Services

  • Visage 7 Enterprise Imaging Platform: A cutting-edge healthcare imaging software that enables radiologists, physicians, and clinicians to access and visualize 2-D, 3-D, and 4-D medical images.
  • Visage RIS: A proprietary medical software solution offering practice management, training, installation, and professional services, along with after-sale support.
  • Promedicus.net: An e-health platform providing secure email and integration solutions for healthcare professionals.
  • Visage Ease Pro: A mobile application that allows users to interpret diagnostic imaging studies stored on a Visage 7 server.

Company Background

Founded in 1983, Pro Medicus is headquartered in Richmond, Australia, and has established itself as a trusted provider of innovative healthcare imaging solutions.

Frequently Asked Questions

  • What is Pro Medicus Limited's (ASX-PME) current market cap?
    As of 06/26/2025, Pro Medicus Limited (including the parent company, if applicable) has an estimated market capitalization of $18.87 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Pro Medicus Limited global market capitalization ranking is approximately 1111 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.